Pharmaceutical

Kezar stalls solid tumour trial to focus on autoimmune disease candidate

Kezar plans to focus all efforts on zetomipzomib, which is being evaluated in two Phase II trials for lupus and autoimmune hepatitis.

Aug 15, 2024 - 04:00
Kezar stalls solid tumour trial to focus on autoimmune disease candidate
Kezar plans to focus all efforts on zetomipzomib, which is being evaluated in two Phase II trials for lupus and autoimmune hepatitis.
Read the original article

Tags:

Previous Article

Replimune kickstarts Phase III melanoma trial studying RP1 immunotherapy

Next Article

Bavarian Nordic outlays 215,000 mpox vaccine dose supply to African countries

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

How an ER doctor in Chicago is tackling trauma from gun violence

How an ER doctor in Chicago is tackling trauma from gun...

Oct 20, 2023

Opinion: BMI as a barrier to orthopedic surgery doesn’t make sense for patient health

Opinion: BMI as a barrier to orthopedic surgery doesn’t...

Jan 16, 2024

Tavros and OpenBench expand small molecule drug discovery alliance

Tavros and OpenBench expand small molecule drug discove...

Apr 28, 2023